Yatharth Hospital and Trauma Care Services Limited (YATHARTH) AI Stock Analysis

• Market Cap: ₹75.61B
• Dividend Yield: N/A
• Average Volume (3M): 28.00K
• Price to Earnings (P/E): 49.6
• Beta (1Y): 0.94
• Revenue Growth: 27.65%
• EPS Growth: 4.02%
• Country: IN
• Employees: 3,607
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 4.30
• Shares Outstanding: 96,354,355
• 10 Day Avg. Volume: 38,530
• 30 Day Avg. Volume: 28,001
• PEG Ratio: 15.52
• Price to Book (P/B): 2.27
• Price to Sales (P/S): 4.14
• P/FCF Ratio: -22.60
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 1,636.24
• Revenue Forecast (FY): ₹1.06T

• Rating: 73 Outperform
• Price Target: ₹923.00 ▲(13.89% Upside)

Yatharth Hospital's strong financial performance and positive technical indicators are the primary drivers of its stock score. However, the high P/E ratio and lack of dividend yield suggest overvaluation, which tempers the overall score.

Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model

Company Description

Yatharth Hospital and Trauma Care Services Limited (YATHARTH) is a multi-specialty healthcare provider that focuses on delivering comprehensive medical services, including trauma care, emergency services, inpatient and outpatient care, and advanced surgical procedures. The hospital is equipped with state-of-the-art facilities and a team of experienced healthcare professionals, aiming to provide high-quality healthcare solutions to its patients. YATHARTH operates in the healthcare sector, with a commitment to enhancing patient outcomes and promoting community health through various specialized services.

How the Company Makes Money

Yatharth Hospital generates revenue primarily through patient services, which include inpatient admissions, outpatient consultations, surgeries, and diagnostic services. The hospital charges fees for various medical services rendered, which are often covered by health insurance plans, contributing significantly to its income. Additionally, YATHARTH may generate revenue through partnerships with insurance companies and government health programs that reimburse for treatments provided to insured patients. Other potential revenue streams could include ancillary services such as pharmacy sales, laboratory tests, and wellness programs. The hospital's focus on quality care and its reputation in the community also play crucial roles in attracting more patients and thereby increasing its earnings.

Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview

Summary

Yatharth Hospital shows strong revenue growth and improved profitability, with a high gross profit margin and a better debt-to-equity ratio. However, the negative free cash flow due to high capital expenditures indicates a need for careful investment management.

Income Statement

Yatharth Hospital has demonstrated strong revenue growth, with a significant increase from 2020 to 2025. The gross profit margin is consistently high, indicating efficiency in cost management. Net profit margin has improved, showcasing enhanced profitability. However, the slight drop in EBIT margin over the years suggests room for operational efficiency improvements.

Balance Sheet

The company's debt-to-equity ratio has improved significantly, reflecting a stronger equity base and reduced leverage. The substantial increase in stockholders' equity indicates robust growth in assets relative to liabilities. However, the high increase in total assets compared to liabilities suggests potential over-leverage if not managed properly.

Cash Flow

Operating cash flow has improved from negative to positive, signifying better cash management. However, free cash flow remains negative due to high capital expenditures, indicating ongoing investments in growth. The operating cash flow to net income ratio has improved, but sustaining this trend is crucial for long-term financial health.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	9.26B	8.80B	6.71B	5.20B	4.01B	2.29B
Gross Profit	6.25B	5.39B	5.37B	4.27B	3.20B	1.82B
EBITDA	2.53B	2.36B	1.96B	1.37B	1.13B	675.27M
Net Income	1.42B	1.31B	1.14B	657.68M	441.62M	181.60M
Balance Sheet
Total Assets	0.00	17.31B	10.19B	4.86B	4.26B	3.09B
Cash, Cash Equivalents and Short-Term Investments	5.15B	5.15B	2.39B	382.36M	120.31M	51.52M
Total Debt	0.00	115.86M	846.47M	2.67B	2.64B	1.93B
Total Liabilities	-16.37B	940.45M	1.45B	3.03B	3.09B	2.28B
Stockholders Equity	16.37B	16.05B	8.74B	1.83B	1.17B	724.55M
Cash Flow
Free Cash Flow	0.00	-1.61B	-964.43M	439.70M	468.01M	235.38M
Operating Cash Flow	0.00	1.50B	-30.78M	637.84M	599.35M	436.73M
Investing Cash Flow	0.00	-4.20B	-2.26B	-203.10M	-521.75M	-212.38M
Financing Cash Flow	0.00	5.19B	3.04B	-177.48M	-11.24M	-190.50M

Yatharth Hospital and Trauma Care Services Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 810.40
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Neutral. The current price of 810.4 is above the 20-day moving average (MA) of 783.14, above the 50-day MA of 787.98, and above the 200-day MA of 596.07, indicating a neutral trend. The MACD of -4.85 indicates Positive momentum. The RSI at 47.50 is Neutral, neither overbought nor oversold. The STOCH value of 61.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:YATHARTH.

Yatharth Hospital and Trauma Care Services Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
YATHARTH	73 Outperform	₹75.61B	49.58	―	―	27.65%	4.02%
INDRAMEDCO	69 Neutral	₹46.90B	26.84	―	0.88%	6.51%	18.24%
HCG	67 Neutral	₹107.77B	287.35	―	―	17.58%	-38.20%
KIMS	65 Neutral	₹287.00B	76.23	―	―	25.74%	1.41%
ASTERDM	62 Neutral	₹356.83B	108.59	―	0.75%	-36.14%	-93.99%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SHALBY	48 Neutral	₹26.27B	-5,142.71	―	0.58%	11.49%	-91.65%

Yatharth Hospital and Trauma Care Services Limited Corporate Events

Yatharth Hospital’s 18th AGM Resolutions Approved

Yatharth Hospital & Trauma Care Services Limited successfully concluded its 18th Annual General Meeting on September 30, 2025, with all proposed resolutions approved by the requisite majority. The meeting was conducted via video conferencing, and the results, along with the Scrutinizer’s Report, have been disclosed in compliance with SEBI regulations. This development underscores the company’s commitment to transparency and effective governance, potentially strengthening its position in the healthcare industry.

Yatharth Hospital Announces 18th AGM with E-Voting Facility

Yatharth Hospital & Trauma Care Services Limited has announced the convening of its 18th Annual General Meeting (AGM) scheduled for September 30, 2025, to be held via video conferencing. The company is providing e-voting facilities to its members, allowing them to vote on resolutions prior to the meeting, reflecting its commitment to engaging stakeholders and adhering to regulatory requirements.

Yatharth Hospital Appoints New Statutory Auditors

Yatharth Hospital & Trauma Care Services Limited has announced a change in its statutory auditors, appointing M/s. MSKA & Associates, a member firm of BDO International, as the new auditors for the company and its material subsidiary, AKS Medical & Research Centre Private Limited. This change follows the resignation of the previous auditors and is subject to approval at the upcoming Annual General Meeting. The appointment is expected to enhance the company’s audit and assurance capabilities, potentially impacting its financial reporting and compliance processes.

Yatharth Hospital Announces Key Appointments and Financial Results

Yatharth Hospital and Trauma Care Services Limited announced key decisions from its board meeting, including the approval of un-audited financial results for the first quarter of 2025 and the appointment of M/s MKP & Associates as Secretarial Auditor for a five-year term. The company also re-appointed M/s Subodh Kumar & Co. as Cost Auditor for the financial year 2025-26 and appointed M/s Saurav Upadhyay & Associates as Scrutinizer for its upcoming Annual General Meeting. These appointments and financial disclosures are expected to enhance the company’s governance and operational transparency, potentially strengthening its position in the healthcare sector.

Yatharth Hospital Announces Auditor Resignation

Yatharth Hospital & Trauma Care Services Limited announced a change in its auditors, with M/s. R Nagpal Associates resigning as the statutory auditor of the company and M/s. MAPPS & Company resigning as the auditor of its material subsidiary, AKS Medical & Research Centre Private Limited. The resignations were due to disagreements over the proposed remuneration, which the auditors felt was not commensurate with the efforts required to conduct a thorough audit. This change may impact the company’s financial reporting and auditing processes, potentially affecting stakeholders’ confidence.